Home/Protocols/Ipamorelin
Protocol Reference
Human trial data

Ipamorelin protocol

Ipamorelin (selective growth hormone secretagogue). Dosing on this page comes from a published human trial or an approved product label, cited below.

Category
Growth Hormone Axis
Common vials
10 mg
Half-life
~2 hours
Route in the literature
Subcutaneous, intravenous in trials
Evidence level
Human trial data

How Ipamorelin works

A pentapeptide agonist at the ghrelin receptor (GHS-R1a). Its selling point in the literature is selectivity — unlike earlier secretagogues it releases GH without meaningfully raising cortisol or prolactin.

Ipamorelin dosing schedule

From the phase 2 proof-of-concept trial in postoperative ileus, which is the compound’s main human trial. Read the result alongside the schedule: ipamorelin did not separate from placebo on the primary endpoint. Median time to first tolerated meal was 25.3 hours versus 32.6 hours for placebo, which did not reach significance (p = 0.15).

PhaseAmountFrequencyNotes
Trial arm0.03 mg/kgTwice daily, intravenous infusionThe only amount studied. 114 patients in the safety and modified intent-to-treat populations.

Study length: Postoperative day 1 through day 7 or hospital discharge, whichever came first.

Source for this schedule: Beck DE et al., "Prospective, randomized, controlled, proof-of-concept study of the ghrelin mimetic ipamorelin for the management of postoperative ileus", Int J Colorectal Dis 2014 (NCT00672074). This reproduces what was administered in that work. It is reference information about a study, not a recommendation, and the trial population, monitoring and endpoints are part of what made it a protocol.

Reconstitution and measurement

This part is arithmetic and does not depend on the evidence level. Concentration is vial size divided by the bacteriostatic water you add. Draw volume is your target amount divided by that concentration. Units are draw volume times 100, because a U-100 syringe reads 100 units per millilitre. Common vials for Ipamorelin: 10 mg.

Open the Ipamorelin calculator → Unit converter

Storage and stability

Dry powder
Cold, dark and dry. Lyophilized peptide is the stable form — keep it that way until you intend to use it.
After reconstitution
Refrigerate at 2–8 °C, protect from light, and plan around a limited window. Do not freeze a reconstituted vial — freeze-thaw damages peptides.
Mixing
Run bacteriostatic water down the inside wall of the vial rather than onto the powder, then swirl. Never shake.
Inspect before use
A clear solution is expected. Cloudiness or particles mean discard, not use.

Full storage guide → · Cloudy solution?

Reported effects

  • Reported as well tolerated in the phase 2 trial, with no significant safety signal against placebo.
  • Efficacy was not demonstrated for the indication studied.
  • The selectivity claim — GH release without cortisol or prolactin elevation — comes from earlier pharmacology work rather than this trial.

Sourcing Ipamorelin

Whatever you are working with, the documentation matters more than the price. Ask for a batch certificate of analysis whose lot number matches the vial you actually receive — a COA for a different batch tells you nothing about yours.

Ipamorelin at Summit Research Supply → Grade a COA first

Summit is the supplier we feature and an affiliate link. Our COA checklist applies the same way to any vendor.

For laboratory research use only. This page documents what the published literature reports about Ipamorelin. It is not a recommendation, not a treatment plan, and not medical advice. Compounds referenced are sold strictly as research chemicals and are not for human or veterinary use. Some supplier links are affiliate links and may earn us a commission. This never affects tier placement or review conclusions.
Summit Research Supply
Summit Research Supply — COA-verified research peptidesThird-party tested · U.S. fulfillment · new researchers save 10%
Shop →